MyTherapy App and Charité Kick off Research Project on Post-Transplant Adherence

smartpatientCharité University of Berlin and the MyTherapy App step up their game collaborating on a new research project. A previous pilot study with Prof Elisabeth Steinhagen-Thiessen showed that MyTherapy has a positive impact on medication adherence among elderly patients. In a new research project starting 01 August 2016, kidney transplant patients will use MyTherapy as part of their post-transplant care routines. Under the leadership of Prof. Dr Klemens Budde, 100 patients will use the MyTherapy App over six months. The app (iOS und Android) will act as a support tool for the patients for adhering to their medication regimes, home measurements (e.g. blood pressure) as well as other treatment-related activities. The Charité researchers will evaluate the app’s effectiveness in comparison to a control group of the same size.

It is important especially for transplant patients to fully adhere to their prescribed medications, as the danger of complications after a transplant can otherwise increase. According to Prof Budde “every 1 in 6 kidneys is rejected due to poor adherence”. Prof Budde continues that “based on the positive study results from MyTherapy, we believe this app will help improve post-transplant outcomes”. The results of the study will be presented at an upcoming Nephrology Conference.

About MyTherapy
Keep track of your medications and stay on top of your health. The award-winning MyTherapy app reminds you of the medications you need to take and to get active by tracking your vitals and symptoms. MyTherapy’s built-in health journal summarises your medication and health information so you can oversee your health progress. You can share them with your healthcare provider, helping them better understand your needs or let your family be your safety net, in case you do forget a dose. MyTherapy keeps you in charge of your personal data at all times with strict privacy policies prohibiting the distribution to third parties. MyTherapy’s proven impact on medication adherence and its outstanding ease of usability for patients of all age groups has been demonstrated by several studies with reputable research institutes including Germany’s largest university hospital Charité Berlin. MyTherapy is available free of charge from the iTunes App Store and on Google Play.

For more information please visit: www.mytherapyapp.com

About smartpatient
smartpatient helps patients to take their medication and to implement a healthy lifestyle. Patients of a wide range of conditions and all ages trust smartpatient’s award-winning MyTherapy platform for managing their medication. Clinically evaluated and strictly protecting users’ privacy, MyTherapy stands out as the European answer to digitally supporting the chronically ill. Partners from academia and the healthcare industry rely on smartpatient for improving health outcomes. MyTherapy is available for free on the iTunes App Store and Google Play.

Sebastian Gaede, Philipp Legge and Julian Weddige founded smartpatient in late 2012. The Munich-based company received numerous awards for the MyTherapy platform and the underlying research. Lately smartpatient won the "Smart Service World" technology contest of the German Federal Ministry for Economic Affairs and Energy.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...